Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Clinical trial NCT06784193 · RECRUITING

Trial details

NCT number: NCT06784193
Sponsor: Olema Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)Metastatic Breast Cancer Fulvestrant Palazestrant

Start date: 2024-12-16
Primary completion: 2027-05-30
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.